Viewing Study NCT06486688



Ignite Creation Date: 2024-07-17 @ 11:10 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06486688
Status: RECRUITING
Last Update Posted: 2024-07-08
First Post: 2024-06-19

Brief Title: Centralized Virtual SBIRT for Pediatric Primary Care
Sponsor: Kaiser Permanente
Organization: Kaiser Permanente

Study Overview

Official Title: Virtual SBIRT for Pediatric Primary Care Increasing Access to Screening Brief Intervention and Referral to Treatment for Alcohol and Other Drug Use Via Telehealth
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Adolescent alcohol and other drug AOD use is a significant public health problem which contributes to high levels of mortality morbidity and healthcare costs in young people and identification and early intervention for these problems is critical to improving outcomes Screening Brief Intervention and Referral to Treatment SBIRT in pediatric primary care is an evidence-based strategy for addressing these problems but has not been widely and systematically implemented for a variety of reasons including lack of training and staffing resources to support its implementation This pragmatic Type 1 Hybrid Comparative Effectiveness Implementation study will examine whether a centralized virtually-delivered modality of SBIRT rapidly accessible by multiple pediatric primary care clinics can be cost-effectively implemented to improve early identification and treatment for AOD use and comorbid mental health problems among adolescents identified as being at high or severe risk of AOD use disorder during adolescent Well Visits
Detailed Description: Adolescent alcohol and other drug AOD use is a major public health concern posing significant challenges to healthcare providers patients and families It is associated with comorbid psychiatric and medical conditions poor educational and employment outcomes accidents and injuries and avoidable health services utilization and costs eg emergency and inpatient Early AOD use initiation is associated with alcohol use disorders in adulthood Screening Brief Intervention and Referral to Treatment SBIRT delivered in pediatric primary care is an effective approach to early identification and intervention and can reduce both AOD use and consequences and co-occurring mental health symptoms yet widespread implementation is lacking due to a variety of barriers including the time constraints and competing priorities faced by pediatricians and lack of trained staff Research on efficient and cost-effective modalities of SBIRT delivery in pediatric primary care is critical to expanding the evidence base and supporting broader implementation Accelerated by the pandemic behavioral telemedicine approaches to addressing adolescent AOD use and mental health problems are gaining momentum and offer the potential to increase the reach and impact of SBIRT in pediatric primary care This studys objective is to examine whether a centralized virtually delivered modality of SBIRT rapidly accessible by multiple pediatric primary care clinics can be cost-effectively implemented to improve early identification and treatment for AOD and comorbid mental health problems among adolescents at high or severe risk of AOD use disorder In this wholly pragmatic Type 1 Hybrid Comparative Effectiveness Implementation study set in a large real-world health system with a highly diverse population we will compare outcomes in two models of busy general pediatric primary care clinics with an eligible population of approximately 22320 12-17 year old adolescents 1 clinics where brief interventions are delivered virtually by video or telephone by a centralized behavioral health clinician CV-SBIRT arm or 2 clinics where appointment-based brief interventions are delivered by a behavioral health clinician assigned to the clinic Traditional SBIRT arm

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None